Angiodynamics (ANGO) Cash from Financing Activities (2010 - 2026)
Angiodynamics' (ANGO) quarterly Cash from Financing Activities came in at -$108000.0 in Q2 2026, up 98.13% YoY from -$54510.1 in Q2 2025, and down 117.39% on a QoQ basis from $621000.0 in Q1 2026.
Angiodynamics (ANGO) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Angiodynamics (ANGO) has 17 years of Cash from Financing Activities data on file, last reported at -$108000.0 in Q2 2026.
- Quarterly Cash from Financing Activities rose 98.13% year-over-year to -$108000.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $564000.0 (up 321.18% YoY) and the FY2026 annual result came in at $564000.0, up 321.18% from the prior year.
- Cash from Financing Activities eased to -$108000.0 in Q2 2026, from $621000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $24.4 million in Q3 2022 to a low of -$59.6 million in Q3 2023.
- A 5-year average of -$2.2 million and a median of $103000.0 in 2022 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities slumped 441.75% — and 2025, when it surged 929.83%.
- Tracing ANGO's Cash from Financing Activities over 5 years: stood at $103000.0 in 2022, then tumbled by 441.75% to -$352000.0 in 2023, then sank by 219.03% to -$1.1 million in 2024, then surged by 91.81% to -$92000.0 in 2025, then decreased by 17.39% to -$108000.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$108000.0 (Q2 2026), $621000.0 (Q1 2026), and -$92000.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Angiodynamics | 655.49 Mn | 601.62 Mn | 46.77 Mn | -108,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -108,000.00 |
| May 31, 2026 | -108,000.00 |
| Feb 28, 2026 | 621,000.00 |
| Feb 28, 2026 | 621,000.00 |
| Nov 30, 2025 | -92,000.00 |
| Nov 30, 2025 | -92,000.00 |
| Aug 31, 2025 | 143,000.00 |
| Aug 31, 2025 | 143,000.00 |
| May 31, 2025 | -5.77 Mn |
| May 31, 2025 | -5.77 Mn |
| Feb 28, 2025 | 7.15 Mn |
| Feb 28, 2025 | 7.15 Mn |
| Nov 30, 2024 | -1.12 Mn |
| Nov 30, 2024 | -1.12 Mn |
| Aug 31, 2024 | -509,000.00 |
| Aug 31, 2024 | -509,000.00 |
| May 31, 2024 | -5.00 Mn |
| May 31, 2024 | -5.00 Mn |
| Feb 29, 2024 | 694,000.00 |
| Feb 29, 2024 | 694,000.00 |